Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance

Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the devel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francisca Villanueva-Flores, Andrés Zárate-Romero, Alfredo G. Torres, Alejandro Huerta-Saquero
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ea8024f47a864400801b0a6f7d3cc928
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!